Zymeworks (ZYME) PT Lowered to $7 at JPMorgan
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
Tweet
Share
E-mailGet Alerts ZYME Hot Sheet
Price: $25.79 +2.10%
Rating Summary:
21 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 11 | New: 19
Rating Summary:
21 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 11 | New: 19
Join SI Premium – FREE
JPMorgan analyst Brian Cheng lowered the price target on Zymeworks (NYSE: ZYME) to $7.00 (from $14.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Morgan Stanley Downgrades Sandfire Resources NL (SFR:AU) (SNDFY) to Underweight
- Rio Tinto Ltd. (RIO:AU) (RIO) PT Lowered to GBP148 at Morgan Stanley
- Fortescue Metals Group Ltd. (FMG:AU) (FSUGY) PT Lowered to AUD14.55 at Morgan Stanley
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
